Form 8-K - Current report:
SEC Accession No. 0001104659-21-043921
Filing Date
2021-03-30
Accepted
2021-03-30 16:46:49
Documents
3
Period of Report
2021-03-30
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2111289d1_8k.htm 8-K 16071
2 EXHIBIT 99.1 tm2111289d1_ex99-1.htm EX-99.1 193885
3 GRAPHIC tm2111289d1_ex99-1img001.jpg GRAPHIC 8416
  Complete submission text file 0001104659-21-043921.txt   222872
Mailing Address 400 CROSSING BOULEVARD BRIDGEWATER NJ 08807
Business Address 400 CROSSING BOULEVARD BRIDGEWATER NJ 08807 9088091300
Osmotica Pharmaceuticals plc (Filer) CIK: 0001739426 (see all company filings)

EIN.: 000000000
Type: 8-K | Act: 34 | File No.: 001-38709 | Film No.: 21786648
SIC: 2834 Pharmaceutical Preparations